Skip to main content
. 2009 Oct 9;9:75. doi: 10.1186/1471-230X-9-75

Figure 5.

Figure 5

Forest plot graphic assessing the risk to be free of treatment discontinuation due to neurologic adverse events at rimonabant dosages of 5 and 20 mg.